22 May 2026 | 02:30 PM GMT
Defining the Next Generation of Digital Biomarkers in Metabolic Diseases
This session is exclusive to certain members only.
If you are interested in finding out more, please contact us.
About this Meeting
Digital biomarkers are at an inflection point. While early efforts have focused on disease monitoring, the field is now shifting toward digital phenotyping, leveraging high-frequency, real-world data and advanced analytics to generate deeper, more meaningful insights into patient health.
Join us for a roundtable discussion bringing together experts across the ecosystem to explore how digital biomarkers are evolving, and what new opportunities this shift unlocks, particularly in metabolic diseases.
The conversation will focus on:
Join us for a roundtable discussion bringing together experts across the ecosystem to explore how digital biomarkers are evolving, and what new opportunities this shift unlocks, particularly in metabolic diseases.
The conversation will focus on:
- Lessons learned from the use of digital biomarkers in neurodegenerative diseases
- Emerging opportunities in metabolic diseases and CVRM
- The role of high-frequency data and analytics in shaping a more continuous understanding of disease
- Cross-stakeholder perspectives on where the field is heading and what is needed to move it forward
We will build on the most relevant insights from this session and carry them forward into a continued discussion at HLTH Europe.